Previous studies have shown elevated RAD51 expression levels in prostate cancer, invasive breast cancer and small cell lung cancers [19–22]; however, decreased RAD51 expression levels in breast tumors and breast cancer cell lines have also been reported [23]. Here, RAD51 is linked to prostate carcinoma.